Skip to content
Tuesday, June 17, 2025
Latest:
  • Researchers identified new indicators for HER2+ breast cancer response to therapy
  • Healthy Habits: Feibi Zheng starts her day with stretching
  • What is inflammation? Q&A with Dr. Mike Ren
  • A new treatment can potentially change the outlook for patients with Alagille syndrome
  • Mental health for first-time parents
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
From The Labs

Researchers identified new indicators for HER2+ breast cancer response to therapy

June 17, 2025 Breast Cancer,  CALGB 40601 clinical trial,  GPRC5A,  HER2,  proteogenomics,  Research,  response to treatment,  TPBG

Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951